Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter

Coverage

Ascelia Pharma

Ascelia Pharma

Send subscription Close

Financials

SEKm 2025 2026e 2027e
Sales 0 73,66 71,45
Sales growth (%) N/A N/A -3
EBITDA -74 12 16
EBITDA margin (%) N/A 16,9 22,9
EBIT adj. -74 12 16
EBIT adj. margin (%) N/A 16,9 22,9
Pretax profit -77 12 15
EPS -0,6 0,09 0,12
EPS growth (%) -28,4 N/A 29,6
EPS adj. -0,6 0,09 0,12
Dividend per share 0 0 N/A
EV/EBITDA (x) -4,3 25 18,1
EV/EBIT adj. (x) -4,3 25 18,1
P/E (x) N/A 31,33 24,18
P/E adj. (x) N/A 31,3 24,2
EV/sales (x) N/A 4,22 4,15
FCF yield (%) -19,5 3,2 4,1
Le. adj. FCF yld. (%) -19,7 3 3,9
Dividend yield (%) 0 0 0
Net IB debt/EBITDA (x) 0,7 -4,8 -4,6
Le. adj. ND/EBITDA (x) 0,7 -4,9 -4,6
SEKm 2025 2026e 2027e
Sales 0 73,66 71,45
COGS 0 0 0
Gross profit 0 74 71
Other operating items -74 -61 -55
EBITDA -74 12 16
Depreciation and amortisation 0 0 0
Depreciation on leased assets 0 0 0
EBITA -74,37 12,45 16,34
Operating EO items 0 0 0
Impairment and amortisation charges 0 0 0
EBIT -74,37 12,45 16,34
Net financial items -2 -1 -1
Pretax profit -77 12 15
Tax 0 0 0
Net profit -76 12 15
Minority interest 0 0 0
Net profit discontinued 0 0 0
Net profit to shareholders -76 12 15
EPS -0,6 0,09 0,12
EPS adj. -0,6 0,09 0,12
Total extraordinary items after tax 0 0 0
Leasing payments 0 0 0
Tax rate (%) 0,6 0 0
Gross margin (%) N/A 100 100
EBITDA margin (%) N/A 16,9 22,9
EBITA margin (%) N/A 16,9 22,9
EBIT margin (%) N/A 16,9 22,9
Pre-tax margin (%) N/A 16,1 21,5
Net margin (%) N/A 16,1 21,5
Sales growth (%) N/A N/A -3
EBITDA growth (%) 9,8 -116,7 31,2
EBITA growth (%) 9,8 -116,7 31,2
EBIT growth (%) 9,8 -116,7 31,2
Net profit growth (%) -4,7 -115,5 29,6
EPS growth (%) -28,4 N/A 29,6
Year N/A N/A N/A
ROE (%) -85,5 11,3 13
ROE adj. (%) -85,5 11,3 13
ROCE (%) -69,6 12,5 14,6
ROCE adj. (%) -69,6 12,5 14,6
ROIC (%) -185,6 24,6 32,3
ROIC adj. (%) -185,6 24,6 32,3
EBITDA adj. -74 12 16
EBITDA adj. margin (%) N/A 16,9 22,9
EBITDA lease adj. -74 12 16
EBITDA lease adj. margin (%) N/A 16,9 22,9
EBITA adj. -74 12 16
EBITA adj. margin (%) N/A 16,9 22,9
EBIT adj. -74 12 16
EBIT adj. margin (%) N/A 16,9 22,9
Pretax profit Adj. -77 12 15
Net profit Adj. -76 12 15
Net profit to shareholders adj. -76 12 15
Net adj. margin (%) N/A 16,1 21,5
SEKm 2025 2026e 2027e
EBITDA -74 12 16
Goodwill 0 0 0
Net financial items -2 -1 -1
Other intangible assets 57 57 57
Paid tax 0 0 0
Tangible fixed assets 0 0 0
Non-cash items 25 0 0
Right-of-use asset 1 1 1
Cash flow before change in WC -52 12 15
Other Fixed Assets All 0 0 0
Change in working capital -21 0 0
Fixed assets 58 58 58
Operating cash flow -72 12 15
Inventories 0 0 0
Capex tangible fixed assets 0 0 0
Receivables 3 3 3
Capex intangible fixed assets 0 0 0
Other current assets 1 1 1
Acquisitions and Disposals 0 0 0
Cash and liquid assets 50 61 75
Free cash flow -72 12 15
Total assets 112 123 137
Shareholders equity 99 110 125
Dividend paid 0 0 0
Minority 0 0 0
Share issues and buybacks 69 0 0
Total equity 99 110 125
Leasing liability amortisation -1 -1 -1
Long-term debt 0 0 0
Other changes in net debt 3 0 0
Pension debt 0 0 0
Convertible debt 0 0 0
Leasing liability 1 1 1
Total other long-term liabilities 0 0 0
Short-term debt 0 0 0
Accounts payable 2 2 2
Other current liabilities 9 9 9
Total liabilities and equity 112 123 137
Net IB debt -49 -60 -74
Net IB debt excl. pension debt -49 -60 -74
Net IB debt excl. leasing -50 -61 -75
Capital employed 100 111 126
Capital invested 51 51 51
Working capital -7 -7 -7
Market cap. diluted (m) 371 371 371
Net IB debt adj. -49 -60 -74
Market value of minority 0 0 0
Reversal of shares and participations 0 0 0
Reversal of conv. debt assumed equity N/A N/A N/A
EV 322 311 297
Total assets turnover (%) 0 62,7 54,9
Working capital/sales (%) N/A -10,1 -10,4
Year N/A N/A N/A
Net debt/equity (%) -49,2 -54,2 -59,5
Net debt / market cap (%) -13,2 -16,1 -20,1
Equity ratio (%) 88,9 89,9 90,9
Net IB debt adj. / equity (%) -49,2 -54,2 -59,5
Current ratio 4,69 5,64 6,91
EBITDA/net interest 31,7 20,3 16,3
Net IB debt/EBITDA (x) 0,7 -4,8 -4,6
Net IB debt/EBITDA lease adj. (x) 0,7 -4,9 -4,6
Interest coverage 12,9 9,7 8,7
SEKm 2025 2026e 2027e
Shares outstanding adj. 128 128 128
Diluted shares adj. 128 128 128
EPS -0,6 0,09 0,12
Dividend per share 0 0 N/A
EPS adj. -0,6 0,09 0,12
BVPS 0,78 0,86 0,98
BVPS adj. 0,33 0,42 0,53
Net IB debt/share -0,38 -0,47 -0,58
Share price 2,9 2,9 2,9
Market cap. (m) 371 371 371
P/E (x) N/A 31,33 24,18
EV/sales (x) N/A 4,22 4,15
EV/EBITDA (x) -4,3 25 18,1
EV/EBITA (x) -4,3 25 18,1
EV/EBIT (x) -4,3 25 18,1
Dividend yield (%) 0 0 0
FCF yield (%) -19,5 3,2 4,1
Le. adj. FCF yld. (%) -19,7 3 3,9
P/BVPS (x) 3,73 3,36 2,97
P/BVPS adj. (x) 8,75 6,94 5,46
P/E adj. (x) N/A 31,3 24,2
EV/EBITDA adj. (x) -4,3 25 18,1
EV/EBITA adj. (x) -4,3 25 18,1
EV/EBIT adj. (x) -4,3 25 18,1
EV/CE (x) 3,2 2,8 2,4
Year N/A N/A N/A
Capex/sales (%) N/A 0 0
Capex/depreciation N/A N/A N/A
Capex tangibles / tangible fixed assets 0 0 0
Capex intangibles / definite intangibles 0 0 0
Depreciation on intang / def. intang 0 0 0
Depreciation on tangibles / tangibles 0 0 0

Key Figure Counter

It is not always easy to generate comparative valuations. Therefore, in order to make it easier for you as an investor, we have created this key figure calculator. Enter share price in the field below and then select the year in which you want to retrieve the financial data.

Update

P/E

Learn more

A common valuation multiple, the share price is divided by earnings per share.

P/E ratio stands for Price and Earnings. By dividing a company's market cap to its earnings, investors get a key ratio which they are able to compare between different companies. The ratio can either be calculated on historical or forward-looking numbers. 

It is important to notice that earnings are calculated after taxes, which mean that they can vary between companies due to different accounting standards.

24,2

EV/EBIT

Learn more

EV stands for Enterprise Value and is calculated as a company's markets cap in addition to its net debt. The net debt itself is computed through the company's interest-bearing debt minus total cash and cash equivalents. 

EBIT is the Earnings Before Interest and Taxes which is the operating income. This result, in comparison to the P/E ratio, is not affected by any financial items.

(
)
18,2

EV/Sales

Learn more

EV stands for Enterprise Value and is calculated as a company's market cap adjusted for its net debt. The net debt itself is computed through the company's interest-bearing debt minus total cash and cash equivalents. S is the company's total sales.

(
)
4,2

P/BVPS

Learn more

P/B stands for Price to Book, which is used to compare a share's market cap to its book value. A P/B ratio that is below one is considered to be valued below its assets.

Companies with high return on equity are usually associated with high P/B ratios, and vice versa. 

 

(
)
3,0